AAV-AIPL1

N/A

Report date: 2025/02/25 16:43:04

Base Information

Drug NameAAV-AIPL1
Drug Alias NameAAV-AIPL1AAV-AIPLAAV8-RK-AIPL1rAAV8.hRKp.AIPL1
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGene transferenceAryl Hydrocarbon Receptor Interacting Protein Like 1 modulators
TargetsAryl Hydrocarbon Receptor Interacting Protein Like 1
Therapy Area/IndicationsLeber Congenital Amaurosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesEU
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMeiragtx Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMeiragtx LtdEli Lilly And Company
Inactive CompaniesN/A
Active IndicationsLeber Congenital Amaurosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A